ParkinsonCanadaV1, Main, Exploration, bibRecord, 003D04

Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)

Identifieur interne : 003D04 ( Main/Exploration ); précédent : 003D03; suivant : 003D05

Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)

Auteurs : S. Calne [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; C. Guyette [Canada] ; G. Rohs [Canada] ; S. Hatchard [Canada] ; D. Murphy [Canada] ; J. Hodder [Canada] ; C. Gagnon [Canada] ; S. Weatherby [Canada] ; L. Beaudet [Canada] ; J. Duff [Canada] ; S. Pegler [Canada]

Source :

[ 1353-8020 ]

RBID : ISTEX:F260B3BA9FE1528E239FFB46E3AFEE3D732AEA17

Abstract

The signs and symptoms of idiopathic parkinsonism (IP, Parkinson's disease) are most commonly documented using one or more rating scales that assess physical limitations due to illness and drug side-effects with some attention being paid to depression. Scant attention has been paid to the impact of these limitations on a patient's life. Nurses in the Parkinson Foundation of Canada Clinical Assistance/ Outreach Programmes have designed a Quality of Life Rating Scale (Parkinson's Impact Scale, PIMS) to measure the impact of IP on 10 aspects of a patient's emotional, social and economic life. The scale had to fit onto one side of an 8 × 11 in. piece of paper, take a patient less than 10 min to complete, take fluctuations in symptoms (‘on/off’ attacks) into account, have unambiguous guidelines for the definition of each item, and a simple scoring system. A study was carried out to assess the reliability and validity of the scale. Nurses in nine Movement Disorder Clinics and one Outreach Programme participated. A total of 167 patients were asked to use the scale on three separate occasions, 1 month apart, without referring to the scores they had assigned to the scale in the previous month. Factor analysis identified four factors among the items in the scale: psychological, social, physical and financial. Internal consistency was 89.8% and the test-retest reliability was 72%. Construct validity was assessed by comparing factor scores and a global score between non-fluctuating patients and fluctuating patients in their ‘off’ state. The scores were significantly higher in the more severe ‘off’ state (p < 0.0001).

Url:

https://api-v5.istex.fr/document/F260B3BA9FE1528E239FFB46E3AFEE3D732AEA17/fulltext/pdf

DOI: 10.1016/1353-8020(95)00026-7

Affiliations:

Canada

Le document en format XML

<record><TEI wicri:istexFullTextTei="no"><teiHeader><fileDesc><titleStmt><title>Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)</title>
<author><name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
</author>
<author><name sortKey="Schulzer, M" sort="Schulzer, M" uniqKey="Schulzer M" first="M." last="Schulzer">M. Schulzer</name>
</author>
<author><name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name>
</author>
<author><name sortKey="Guyette, C" sort="Guyette, C" uniqKey="Guyette C" first="C." last="Guyette">C. Guyette</name>
</author>
<author><name sortKey="Rohs, G" sort="Rohs, G" uniqKey="Rohs G" first="G." last="Rohs">G. Rohs</name>
</author>
<author><name sortKey="Hatchard, S" sort="Hatchard, S" uniqKey="Hatchard S" first="S." last="Hatchard">S. Hatchard</name>
</author>
<author><name sortKey="Murphy, D" sort="Murphy, D" uniqKey="Murphy D" first="D." last="Murphy">D. Murphy</name>
</author>
<author><name sortKey="Hodder, J" sort="Hodder, J" uniqKey="Hodder J" first="J." last="Hodder">J. Hodder</name>
</author>
<author><name sortKey="Gagnon, C" sort="Gagnon, C" uniqKey="Gagnon C" first="C." last="Gagnon">C. Gagnon</name>
</author>
<author><name sortKey="Weatherby, S" sort="Weatherby, S" uniqKey="Weatherby S" first="S." last="Weatherby">S. Weatherby</name>
</author>
<author><name sortKey="Beaudet, L" sort="Beaudet, L" uniqKey="Beaudet L" first="L." last="Beaudet">L. Beaudet</name>
</author>
<author><name sortKey="Duff, J" sort="Duff, J" uniqKey="Duff J" first="J." last="Duff">J. Duff</name>
</author>
<author><name sortKey="Pegler, S" sort="Pegler, S" uniqKey="Pegler S" first="S." last="Pegler">S. Pegler</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F260B3BA9FE1528E239FFB46E3AFEE3D732AEA17</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1016/1353-8020(95)00026-7</idno>
<idno type="url">https://api-v5.istex.fr/document/F260B3BA9FE1528E239FFB46E3AFEE3D732AEA17/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000024</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000024</idno>
<idno type="wicri:Area/Istex/Curation">000024</idno>
<idno type="wicri:Area/Istex/Checkpoint">001713</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001713</idno>
<idno type="wicri:doubleKey">1353-8020:1996:Calne S:validating:a:quality</idno>
<idno type="wicri:Area/Main/Merge">004393</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:18591019</idno>
<idno type="wicri:Area/PubMed/Corpus">001882</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001882</idno>
<idno type="wicri:Area/PubMed/Curation">001882</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001882</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001882</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001882</idno>
<idno type="wicri:Area/Ncbi/Merge">000930</idno>
<idno type="wicri:Area/Ncbi/Curation">000930</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000930</idno>
<idno type="wicri:doubleKey">1353-8020:1996:Calne S:validating:a:quality</idno>
<idno type="wicri:Area/Main/Merge">004343</idno>
<idno type="wicri:Area/Main/Curation">003D04</idno>
<idno type="wicri:Area/Main/Exploration">003D04</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><author><name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Schulzer, M" sort="Schulzer, M" uniqKey="Schulzer M" first="M." last="Schulzer">M. Schulzer</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver</wicri:regionArea>
<wicri:noRegion>Vancouver</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Guyette, C" sort="Guyette, C" uniqKey="Guyette C" first="C." last="Guyette">C. Guyette</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Rohs, G" sort="Rohs, G" uniqKey="Rohs G" first="G." last="Rohs">G. Rohs</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hatchard, S" sort="Hatchard, S" uniqKey="Hatchard S" first="S." last="Hatchard">S. Hatchard</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Murphy, D" sort="Murphy, D" uniqKey="Murphy D" first="D." last="Murphy">D. Murphy</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hodder, J" sort="Hodder, J" uniqKey="Hodder J" first="J." last="Hodder">J. Hodder</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gagnon, C" sort="Gagnon, C" uniqKey="Gagnon C" first="C." last="Gagnon">C. Gagnon</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Weatherby, S" sort="Weatherby, S" uniqKey="Weatherby S" first="S." last="Weatherby">S. Weatherby</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Beaudet, L" sort="Beaudet, L" uniqKey="Beaudet L" first="L." last="Beaudet">L. Beaudet</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Duff, J" sort="Duff, J" uniqKey="Duff J" first="J." last="Duff">J. Duff</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, CanadaEducational Liaison DuPont Pharma Inc.</wicri:regionArea>
<wicri:noRegion>CanadaEducational Liaison DuPont Pharma Inc.</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Pegler, S" sort="Pegler, S" uniqKey="Pegler S" first="S." last="Pegler">S. Pegler</name>
<affiliation wicri:level="1"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Educational Liaison DuPont Pharma Inc.</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><idno type="ISSN">1353-8020</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1353-8020</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The signs and symptoms of idiopathic parkinsonism (IP, Parkinson's disease) are most commonly documented using one or more rating scales that assess physical limitations due to illness and drug side-effects with some attention being paid to depression. Scant attention has been paid to the impact of these limitations on a patient's life. Nurses in the Parkinson Foundation of Canada Clinical Assistance/ Outreach Programmes have designed a Quality of Life Rating Scale (Parkinson's Impact Scale, PIMS) to measure the impact of IP on 10 aspects of a patient's emotional, social and economic life. The scale had to fit onto one side of an 8 × 11 in. piece of paper, take a patient less than 10 min to complete, take fluctuations in symptoms (‘on/off’ attacks) into account, have unambiguous guidelines for the definition of each item, and a simple scoring system. A study was carried out to assess the reliability and validity of the scale. Nurses in nine Movement Disorder Clinics and one Outreach Programme participated. A total of 167 patients were asked to use the scale on three separate occasions, 1 month apart, without referring to the scores they had assigned to the scale in the previous month. Factor analysis identified four factors among the items in the scale: psychological, social, physical and financial. Internal consistency was 89.8% and the test-retest reliability was 72%. Construct validity was assessed by comparing factor scores and a global score between non-fluctuating patients and fluctuating patients in their ‘off’ state. The scores were significantly higher in the more severe ‘off’ state (p < 0.0001).</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><country name="Canada"><noRegion><name sortKey="Calne, S" sort="Calne, S" uniqKey="Calne S" first="S." last="Calne">S. Calne</name>
</noRegion>
<name sortKey="Beaudet, L" sort="Beaudet, L" uniqKey="Beaudet L" first="L." last="Beaudet">L. Beaudet</name>
<name sortKey="Duff, J" sort="Duff, J" uniqKey="Duff J" first="J." last="Duff">J. Duff</name>
<name sortKey="Gagnon, C" sort="Gagnon, C" uniqKey="Gagnon C" first="C." last="Gagnon">C. Gagnon</name>
<name sortKey="Guyette, C" sort="Guyette, C" uniqKey="Guyette C" first="C." last="Guyette">C. Guyette</name>
<name sortKey="Hatchard, S" sort="Hatchard, S" uniqKey="Hatchard S" first="S." last="Hatchard">S. Hatchard</name>
<name sortKey="Hodder, J" sort="Hodder, J" uniqKey="Hodder J" first="J." last="Hodder">J. Hodder</name>
<name sortKey="Mak, E" sort="Mak, E" uniqKey="Mak E" first="E." last="Mak">E. Mak</name>
<name sortKey="Murphy, D" sort="Murphy, D" uniqKey="Murphy D" first="D." last="Murphy">D. Murphy</name>
<name sortKey="Pegler, S" sort="Pegler, S" uniqKey="Pegler S" first="S." last="Pegler">S. Pegler</name>
<name sortKey="Rohs, G" sort="Rohs, G" uniqKey="Rohs G" first="G." last="Rohs">G. Rohs</name>
<name sortKey="Schulzer, M" sort="Schulzer, M" uniqKey="Schulzer M" first="M." last="Schulzer">M. Schulzer</name>
<name sortKey="Weatherby, S" sort="Weatherby, S" uniqKey="Weatherby S" first="S." last="Weatherby">S. Weatherby</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D04 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D04 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:F260B3BA9FE1528E239FFB46E3AFEE3D732AEA17
   |texte=   Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)
}}

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022

La maladie de Parkinson au Canada (serveur d'exploration)

Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)

Validating a quality of life rating scale for idiopathic parkinsonism: Parkinson's Impact Scale (PIMS)

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	La maladie de Parkinson au Canada (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.